Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia

Cancer

Volumn 107, Issue 9, 2006, Pages 2152-2159

  Smith, Alicia ^a,b   Young, Graeme P ^b,c   Cole, Stephen R ^a,b   Bampton, Peter ^c  

^a REPATRIATION GENERAL HOSPITAL   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Colorectal cancer; Fecal occult blood test; Guaiac; Immunochemical test; Screening

Indexed keywords

GUAIAC;

ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST; DIET RESTRICTION; FALSE POSITIVE RESULT; FECAL IMMUNOCHEMICAL TEST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; OCCULT BLOOD TEST; PRIORITY JOURNAL;

ADENOMA; AGED; AUSTRALIA; COHORT STUDIES; COLORECTAL NEOPLASMS; FALSE POSITIVE REACTIONS; FECES; FEMALE; GUAIAC; HEMOGLOBINS; HUMANS; IMMUNOCHEMISTRY; INDICATORS AND REAGENTS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 33750511303     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22230     Document Type: Article

References (34)

1. Young GP, Macrae FA, St John DJB. Clinical methods of early detection: basis, use and evaluation. In: Young GP, Rozen P, Levin B, editors. Prevention and Early Detection of Colorectal Cancer. London: Saunders; 1996:241-270.
2. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology. 2003;124:544-560.
3. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365-1371.
4. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet. 1996;348:1472-1477.
5. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet. 1996;348:1467-1471.
6. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603-1607.
7. Watson JMG, Jungner G. Principles and Practice of Screening for Disease. World Health Organization Public Health Paper 34; 1968.
8. Allison JE. Screening for colorectal cancer 2003: Is there still a role for the FOBT? Tech Gastrointest Endosc. 2003;5:127-133.
9. Podolsky DK. Going the distance - The case for true colorectal cancer screening. N Engl J Med. 2000;343:207-208.
10. Detsky AS. Screening for colon cancer - Can we afford colonoscopy? N Engl J Med. 2001;345:607-608.
11. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: Screening recommendations of the American College of Gastroenterology. Am J Gastroenterol. 2000;95:868-877.
12. Lieberman DA, Weiss DG; Veterans Affairs Cooperative Study Group 380. One time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001;345:555-560.
13. Allison JE, Tekewa JS, Ransom LJ, Adrian AL. A comparison of fecal occult blood tests for colorectal cancer screening. N Engl J Med. 1996;334:144-159.
14. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med. 2004;351:2704-2714.
15. Petty MT, Deacon MC, Alexeyeff MA, St John DJ, Young GP. Readability and sensitivity of a new faecal occult blood test in a hospital ward environment. Med J Aust. 1992;156:420-423.
16. Young GP, Rozen P, Levin B. How should we screen for early colorectal neoplasia. In: Rozen P, Young GP, Levin B, Spann SJ, editors. Colorectal Cancer in Clinical Practice. London: Martin Dunitz; 2002. p.77-99.
17. Allison JE, Fledman R, Tekawa I. Hemoccult screening in detecting colorectal neoplasms: sensitivity, specificity and predictive value. Ann Intern Med. 1999;112:328-333.
18. Feinberg EJ, Steinberg WM, Banks BL, Henry JP. How long to abstain from eating red meat before fecal occult blood tests. Ann Intern Med. 1990;113:403-404.
19. Lynch NM, McHutchison JG, Young GP, Deacon M, St John DJB, Barraclough D. Gastrointestinal blood loss from a new buffered aspirin (Ostoprin): Measurement by radiochromium and HemoQuant™ techniques. Aust NZ J Med. 1989;19:89-96.
20. Cole SR, Young GP. Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer. Med J Aust. 2001;175:195-198.
21. Young GP, St John DJB. Faecal occult blood tests, choice, usage and clinical applications. Clin Biochem Rev. 1992;13:161-167.
22. Ahlquist DA, Schwartz S, Isaacson J, Ellefson M. A stool collection device: the first step in occult blood testing. Ann Intern Med. 1988;108:609-612.
23. Young GP, St John DJB, Cole SR, et al. A prescreening evaluation of a brush-based faecal immunochemical test for haemoglobin. J Med Screening. 2003;10:123-128.
24. Cole SR, Young GP, Esterman A, Cadd B, Morcom J. A randomized trial of the impact of new fecal hemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screening. 2003;10:117-122.
25. Young GP. Screening for colorectal cancer: Alternative fecal occult blood tests. Eur J Gastroenterol Hepatol. 1998;10:205-212.
26. Bampton PA, Sandford JJ, Cole SR, et al. Interval Faecal Occult Blood Testing in a Colonoscopy Based Screening Program Detects Additional Pathology. Gut. 2005;54:803-806.
27. NHMRC. Guidelines for the prevention, early detection and management of colorectal cancer. Canberra: NHMRC; 1992: Chapter 3.
28. St John DJB, Young GP, Alexeyeff MA, et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology. 1993;104:1661-1668.
29. Gardner MJ, Altman DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. BMJ. 1986;292:746-750.
30. Fielding LP. Staging Systems. In: Cohen AM, Winawer SJ, Friedman MA, Gynderson LJ, editors. Cancer of the colon, rectum and anus. New York: McGraw-Hill, 1995:207-215.
31. Woolf SH: The best screening test for colorectal cancer - A personal choice. N Engl J Med. 2000;343:1641-1643.
32. Fletcher RH: Screening colonoscopy: Option or preference? Gastrointest Endosc. 2000;51:624-627.
33. Young GP, St John DJB, Winawer SJ, Rozen P. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies. Am J Gastroenterol. 2002;97:2499-2507.
34. Wong B CY, Wong WM, Cheung KL, et al. A Sensitive Guaiac Fecal Occult Blood Test is Less Useful than an Immunochemical Test for Colorectal Cancer Screening in a Chinese Population. Alim Pharmacol Therap. 2003;18:941-946.